Urologix, Inc. (ULGX) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-1.14M
Depreciation and amortization	361K
Employee stock-based compensation expense	53K
Provision for bad debts
Loss on disposal of assets
Implied interest on deferred acquisition payments
Accounts receivable	90K
Inventories	99K
Prepaid and other assets	-97K
Accounts payable	-184K
Accrued expenses and deferred income	-72K
Net cash used for operating activities	-172K
Purchase of property and equipment	-8K
Acquisition of business
Net cash used for investing activities	-54K
Proceeds from stock option exercises
Net cash provided by financing activities
Net decrease in cash and cash equivalents	-226K
Beginning of period	718K
End of period	492K
Income taxes paid during the period	9K
Net amount of inventory transferred to property and equipment	25K
Non-cash consideration for acquisition

Entities mentioned with ULGX

View All Entities